Skip to main content

Advertisement

SpringerLink
Log in

Diffuse large B-cell lymphomas with plasmablastic differentiation

  • Published:
Current Oncology Reports Aims and scope Submit manuscript

Abstract

Recent evidence suggests that diffuse large B-cell lymphoma (DLBCL) with plasmablastic differentiation represents a clinically heterogeneous spectrum with different clinicopathologic characteristics representing distinct entities. Subtypes of DLBCL with plasmablastic features and terminal B-cell differentiation include plasmablastic lymphoma (PBL) of oral mucosa type; PBL with plasmacytic differentiation; primary effusion lymphoma (PEL); KSHV-positive solid lymphoma/extracavitary PEL/HHV-8 associated DLBCL; and DLBCL expressing ALK. In contrast, PBL associated with multicentric Castleman disease, DLBCL with secretory differentiation, pyothorax-associated lymphoma, and atypical Burkitt lymphoma with plasmacytoid differentiation have morphologic appearances of plasma cell differentiation but maintain a mature B-cell (CD20 positive) phenotype. These tumors as well as extramedullary plasmablastic tumors secondary to multiple myeloma or plasmacytomas are included in the differential diagnosis. In this review, we discuss recently described clinicopathologic insights, case observations, and recently reported molecules involved in terminal B-cell or plasma cell differentiation and their possible roles in disease pathogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jaffe E, Harris N, Stein H, Vardiman J: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.

    Google Scholar 

  2. Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al.: Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997, 89:1413–1420.

    PubMed  CAS  Google Scholar 

  3. Teruya-Feldstein J, Chiao E, Filippa DA, et al.: CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004, 15:1673–1679.

    Article  PubMed  CAS  Google Scholar 

  4. Leoncini L, Delsol G, Gascoyne RD, et al.: Aggressive B-cel lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology. Histopathology 2005, 46:241–255.

    Article  PubMed  CAS  Google Scholar 

  5. Colomo L, Loong F, Rives S, et al.: Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004, 28:736–747. Discusses and reviews distinct clinical, morphologic, and immunophenotypic features of subtypes of diffuse large B-cell lymphomas with plasmablastic differentiation.

    Article  PubMed  Google Scholar 

  6. Verma S, Nuovo GJ, Porcu P, et al.: Epstein-Barr virus-and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 2005, 32:35–39.

    Article  PubMed  Google Scholar 

  7. Jordan LB, Lessells AM, Goodlad JR: Plasmablastic lymphoma arising at a cutaneous site. Histopathology 2005, 46:113–115.

    Article  PubMed  CAS  Google Scholar 

  8. Tzankov A, Brunhuber T, Gschwendtner A, Brunner A: Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology 2005, 46:348–350.

    Article  PubMed  CAS  Google Scholar 

  9. Zanetto U, Martin CA, Sapia S, et al.: Re: Cioc AM, Allen C, Kalmar J, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004, 25:41–46. Am J Surg Pathol 2004, 28:1537–1538; author reply 1538.

    Google Scholar 

  10. Cioc AM, Allen C, Kalmar JR, et al.: Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004, 28:41–46.

    Article  PubMed  Google Scholar 

  11. Carbone A, Gloghini A, Gaidano G: Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004, 28:1251–1252.

    PubMed  Google Scholar 

  12. Carbone A, Gloghini A, Gaidano G: Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004, 28:1538–1540; author reply 1540.

    PubMed  Google Scholar 

  13. Chadburn A, Hyjek E, Mathew S, et al.: KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004, 28:1401–1416. Discusses and reviews cases and the literature on KSHV-associated lymphomas, PELs, and solid lymphomas.

    Article  PubMed  Google Scholar 

  14. Deloose ST, Smit LA, Pals FT, et al.: High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005, 19:851–855.

    Article  PubMed  CAS  Google Scholar 

  15. Lin O, Gerhard R, Zerbini MC, Teruya-Feldstein J: Cytologic features of plasmablastic lymphoma: a report of 4 cases. Cancer Cytopathol 2005, 105:139–144.

    Google Scholar 

  16. O’Connell FP, Pinkus JL, Pinkus GS: CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol 2004, 121:254–263.

    Article  PubMed  Google Scholar 

  17. Turley H, Jones M, Erber W, et al.: VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol 1994, 47:418–422.

    PubMed  CAS  Google Scholar 

  18. Banham AH, Turley H, Pulford K, et al.: The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein. J Clin Pathol 1997, 50:485–489.

    PubMed  CAS  Google Scholar 

  19. Shanks JH, Banerjee SS: VS38 immunostaining in melanocytic lesions. J Clin Pathol 1996, 49:205–207.

    PubMed  CAS  Google Scholar 

  20. Banerjee SS, Shanks JH, Hasleton PS: VS38 immunostaining in neuroendocrine tumours. Histopathology 1997, 30:256–259.

    Article  PubMed  CAS  Google Scholar 

  21. Sulzbacher I, Fuchs M, Chott A, Lang S: Expression of VS38 in osteoblasts and stroma cells of bone tumors. Pathol Res Pract 1997, 193:613–616.

    PubMed  CAS  Google Scholar 

  22. Lester R, Li C, Galbraith P, et al.: Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004, 45:1881–1885.

    Article  PubMed  Google Scholar 

  23. Antinori A, Cingolani A, Alba L, et al.: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001, 15:1483–1491.

    Article  PubMed  CAS  Google Scholar 

  24. Navarro JT, Ribera JM, Oriol A, et al.: Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndromerelated non-Hodgkin’s lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol 2001, 112:909–915.

    Article  PubMed  CAS  Google Scholar 

  25. Nador RG, Cesarman E, Chadburn A, et al.: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi’s sarcoma-associated herpes virus. Blood 1996, 88:645–656.

    PubMed  CAS  Google Scholar 

  26. Mate JL, Navarro JT, Ariza A, et al.: Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol 2004, 35:632–635.

    Article  PubMed  Google Scholar 

  27. Oksenhendler E, Boulanger E, Galicier L, et al.: High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002, 99:2331–2336.

    Article  PubMed  CAS  Google Scholar 

  28. Du MQ, Diss TC, Liu H, et al.: KSHV-and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002, 100:3415–3418.

    Article  PubMed  CAS  Google Scholar 

  29. Dupin N, Diss TL, Kellam P, et al.: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000, 95:1406–1412.

    PubMed  CAS  Google Scholar 

  30. Du MQ, Liu H, Diss TC, et al.: Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001, 97:2130–2136.

    Article  PubMed  CAS  Google Scholar 

  31. Sharma R, Abdou S, Plymyer MR, Rohatgi C: Disseminated plasmablastic lymphoma. J Am Coll Surg 2004, 199:654–655.

    Article  PubMed  Google Scholar 

  32. Schichman SA, McClure R, Schaefer RF, Mehta P: HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 2004, 77:291–295.

    Article  PubMed  Google Scholar 

  33. Vasef MA, Medeiros LJ, Yospur LS, et al.: Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol 1997, 10:927–932.

    PubMed  CAS  Google Scholar 

  34. Kremer M, Ott G, Nathrath M, et al.: Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol 2005, 205:92–101.

    Article  PubMed  CAS  Google Scholar 

  35. Delsol G, Lamant L, Mariame B, et al.: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997, 89:1483–1490.

    PubMed  CAS  Google Scholar 

  36. Touriol C, Greenland C, Lamant L, et al.: Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000, 95:3204–3207.

    PubMed  CAS  Google Scholar 

  37. Gascoyne RD, Lamant L, Martin-Subero JI, et al.: ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003, 102:2568–2573.

    Article  PubMed  CAS  Google Scholar 

  38. Chikatsu N, Kojima H, Suzukawa K, et al.: ALK+, CD30-, CD20-large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol 2003, 16:828–832.

    Article  PubMed  Google Scholar 

  39. De Paepe P, Baens M, van Krieken H, et al.: ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003, 102:2638–2641.

    Article  PubMed  Google Scholar 

  40. McManus DT, Catherwood MA, Carey PD, et al.: ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol 2004, 35:1285–1288.

    Article  PubMed  CAS  Google Scholar 

  41. Adam P, Katzenberger T, Seeberger H, et al.: A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation. Am J Surg Pathol 2003, 27:1473–1476.

    Article  PubMed  Google Scholar 

  42. Onciu M, Behm FG, Downing JR, et al.: ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003, 102:2642–2644.

    Article  PubMed  CAS  Google Scholar 

  43. Simonitsch-Klupp I, Hauser I, Ott G, et al.: Diffuse large B-cell lymphomas with plasmablastic/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 2004, 18:146–155.

    Article  PubMed  CAS  Google Scholar 

  44. Petitjean B, Jardin F, Joly B, et al.: Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 2002, 26:724–732.

    Article  PubMed  Google Scholar 

  45. Shapiro-Shelef M, Calame K: Regulation of plasma-cell development. Nat Rev Immunol 2005, 5:230–242. Recent review of molecules playing a role in plasma cell development, differentiation, and regulation.

    Article  PubMed  CAS  Google Scholar 

  46. Laichalk LL, Thorley-Lawson DA: Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005, 79:1296–1307.

    Article  PubMed  CAS  Google Scholar 

  47. Guedez L, Martinez A, Zhao S, et al.: Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors. Blood 2005, 105:1660–1668.

    Article  PubMed  CAS  Google Scholar 

  48. Tiacci E, Orvietani PL, Bigerna B, et al.: Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI. Blood 2005, 105:2812–2820.

    Article  PubMed  CAS  Google Scholar 

  49. Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757–768.

    Article  PubMed  CAS  Google Scholar 

  50. Godfrey A, Anderson J, Papanastasiou A, et al.: Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 2005, 105:2510–2518.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Memorial Sloan-Kettering Cancer Center, 10021, New York, NY, USA

    Julie Teruya-Feldstein MD

Authors
  1. Julie Teruya-Feldstein MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teruya-Feldstein, J. Diffuse large B-cell lymphomas with plasmablastic differentiation. Curr Oncol Rep 7, 357–363 (2005). https://doi.org/10.1007/s11912-005-0062-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11912-005-0062-5

Keywords

Search

Navigation